|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of endothelial cell-specific molecule 1 DNA.|
|ESM-1, AV004503, 0610042H23Rik, Esm1|
|Identical with the Gene Bank Ref. ID sequence except for the point mutation 84 C/T not causing the amino acid variation.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Mouse ESM1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||MG51108-G-F|
|Mouse ESM1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||MG51108-G-H|
|Mouse ESM1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||MG51108-G-M|
|Mouse ESM1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||MG51108-G-N|
|Mouse ESM1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||MG51108-G-Y|
|Product name||Product name|
ESM1 is a secreted protein which is produced by adipocytes. It has been noticed that ESM1 may play some role in obesity-associated vascular disease since circulating ESM-1 levels are reduced in the overweight and obese. ESM1 is mainly expressed in the endothelial cells in human lung and kidney tissues. The expression of ESM1 gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. Recently, ESM1 has been described as a specific biomarker of tip cells during neoangiogenesis. Its expression has been shown to be increase in presence of pro-angiogenic growth factors such as VEGF or FGF-2. In hypervascularized cancers, overexpression of endocan has been detected by immunohistochemistry using monoclonal antibodies against ESM1.